Alzheimer’s Disease

Targeting P. gingivalis infection to treat Alzheimer’s: the evidence

Association of CSF and plasma biomarkers with longitudinal tau accumulation

Phase II/III GAIN trial of a novel lysine-gingipain inhibitor for the treatment of Alzheimer’s

Approval of aducanumab for Alzheimer’s disease

The potential druggability of OAS1 leading to new AD and COVID-19 treatments

Identifying innate immune system genes linked to AD

The challenges of Alzheimer’s disease animal models and the use of human stem cells

The study of retinal vasculopathy to predict, detect and monitor Alzheimer’s disease

Microglia associated with longevity and a lower AD risk

The impact of using human stem cells in dementia research

Future perspectives on the study of retina in Alzheimer’s disease

Identifying a new link between TREM2 and IL-4 signaling in microglia

Future perspectives on the use of human stem cells to model Alzheimer’s disease

The effect of tau protein knockout on stem cells of healthy individuals

Retinal imaging techniques and their applications on Alzheimer’s disease research

The OAS1 gene increases risk of AD and COVID-19